You can view last week's COVID-19 Bulletin HERE.
RELATED FUNDING OPPORTUNITIES & UPDATES TO FUNDING:
FEDERAL FUNDING & UPDATES |
Grant Name: | NIH Urgent Competitive Revisions to Active Grants on the 2019 Novel Coronavirus (2019-nCoV) |
Summary: | The National Institute of Allergy and Infectious Diseases (NIAID) together with the National Institute of General Medical Sciences (NIGMS) has activated the NIH Urgent Award mechanism. The targeted opportunity is intended to provide funds for NIH grantees applying to expand the scope of their active grant. |
Due Dates: | April 8, 2020 |
FEDERAL UPDATES:
Emergency Funding for Federal Research Agencies- The 3rd COVID-19 federal relief package passed last week included emergency funding for Federal Research Agencies
NIH: $945.5 million - for vaccine, therapeutic, and diagnostic research to increase our understanding of COVID-19, including underlying risks to cardiovascular and pulmonary conditions. Funds would remain available until the end of federal fiscal year 2024. All funds are to be utilized to prevent, prepare for, and respond to coronavirus, domestically or internationally.
NSF: $76 million
NASA: $60 million
Department of Energy / Office of Science: $99.5 million
National Endowment for the Humanities: $150 million
National Endowment for the Arts: $75 millionfor grants, including funding to state arts agencies and other partners in an effort to help local, state, and regional communities provide continued access to cultural organizations and institutions of learning.
National Endowment for the Humanities: $75 millionfor grants,including funding for state humanities councils and other partners in an effort to help local, state, and regional communities provide continued access to cultural organizations and institutions of learning
NIH Deputy Director of Extramural Research Video- The public health emergency due to COVID-19 is causing difficulties in many aspects of our lives. My colleagues and I here at NIH are well aware of the challenges being felt in the research community as institutions are closing, people are being asked to practice social distancing, and resources and attention are justifiably focused on public health needs. We are listening to your concerns and are working quickly to develop answers to your many questions.
NIH updated the Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients website with a slew of additional FAQs and new funding opportunities.
NIH published a notice announcing that grant applications submitted late for due dates between March 9, 2020, and May 1, 2020, will be accepted through May 1, 2020. This notice applies to all relevant funding opportunity announcements, including those that indicate no late applications will be accepted. A cover letter providing a justification is not required. NIH will be extending the expiration date of most FOAs expiring between now and May 1.
NSF- Effective March 30, 2020, the research community can prepare and submit separately submitted collaborative proposals from multiple organizations in Research.gov. Proposers can now prepare Full, Research proposals in Research.gov that are:
Single submissions from one organization (available since April 2018)
Single submission collaborative proposals with subawards (available since June 2019)
Separately submitted collaborative proposals from multiple organizations
The Office of Management and Budget (OMB) issued a memorandum authorizing granting agencies to offer flexibility regarding proposal submission practices, post-award management activities and availability of funding for COVID-19 research.
Proposals that are submitted after the published deadline will be considered for acceptance on a case-by-case basis (NIH).
Prior approval for pre-award costs is waived for costs incurred beginning January 20, 2020, through the COVID-19 "public health emergency period" and prior to the effective date of the award (NIH).
Financial and programmatic reports will be accepted if submitted late provided that grantees provide notice to the sponsor, but this may delay subsequent funding (NIH).
Salary and stipends for research personnel can continue to be charged to research awards during this time as long as it is done in a manner consistent with institutional policy, including effort or payroll verification practices (NIH, Department of Defense).
Nonrefundable travel and/or hotel costs for travel that is cancelled/delayed by COVID-19 can be charged to a research award in a manner that is consistent with institutional policy (NIH).
The completion and submission of the Single Audit can be delayed up to 12 months and still allow the grantee to qualify as a "low-risk auditee" (NIH).
Federal Guidance Links:
OMB
NSF
NIH
DOD
FOUNDATIONS / CORPORATE FUNDING & UPDATES |
Grant Name: | |
Summary: | Companies, government agencies, non-profit organizations and academic institutions in approved countries are eligible to apply for COVID-19 related research credits. Leverage our computing capabilities and infrastructure to study potential therapies and vaccines, track critical data, and identify new ways to combat COVID-19. |
Due Dates: | Rolling |
Grant Name: | Pulitzer Center Announces New Grant for Innovative Coronavirus Reporting Collaborations |
Summary: | Grants will be awarded in support of innovative approaches to reporting on the novel coronavirus crisis using collaboration among journalists and newsrooms across state lines or national borders.... |
Due Dates: | Rolling |
Grant Name: | AI Techniques to Mitigate Pandemic [Microsoft, C3.ai, and various universities] |
Summary: | Topics for research awards may include but are not limited to the following: Applying machine learning and other AI methods to mitigate the spread of the COVID-19 pandemic; Genome-specific COVID-19 medical protocols, including precision medicine of host responses; Biomedical informatics methods for drug design and repurposing; Design and sharing of clinical trials for collecting data on medications, therapies, and interventions; Modeling, simulation, and prediction for understanding COVID-19 propagation and efficacy of interventions; Logistics and optimization analysis for design of public health strategies and interventions; Rigorous approaches to designing sampling and testing strategies; Data analytics for COVID-19 research harnessing private and sensitive data; and Improving societal resilience in response to the spread of the COVID-19 pandemic. |
Due Dates: | May 1, 2020 |
Grant Name: | |
Summary: | NCBiotech’s Flash Grant program aims to identify and energize the most creative ideas that exhibit early indications of commercial potential. The current cycle is open only to the following topics: · Global Coronavirus disease (COVID-19) outbreak - vaccine development, diagnosis, and COVID-19 specific therapies · Precision health ·Digital and data-driven life science technologies (see page 2 for details) |
Due Dates: | April 22, 2020, 12:00 p.m. |
UPDATES:
North Carolina Arts Council, message from the Director.
RESEARCH DEVELOPMENTS & RELATED ARTICLES
A message from Ece Karatan, Vice Provost for Research.
InfoEd Coronavirus Link to resource and funding database.
Earlier this week, the NLM released the COVID-19 Open Research Dataset (CORD-19) of scholarly literature related to COVID-19, SARS-CoV-2, and the Coronavirus group.
To make full use of this dataset, the White House Office of Science and Technology Policy (OSTP) has issued a call for tech and AI experts to develop new text and data mining techniques that can be used to help the science community answer high-priority scientific questions related to COVID-19.
Americans for Medical Progress and States United for Biomedical Research invite you to take part in a comprehensive survey on the biomedical research community’s response to the COVID-19 pandemic.
They hope to release the preliminary results from this anonymous survey on Friday, April 3rd. They are also planning to host a webinar the week of April 6th to review the responses and address resulting questions.
LitCovid is a curated literature hub for tracking up-to-date scientific information about the 2019 novel Coronavirus. It is the most comprehensive resource on the subject, providing a central access to 842 (and growing) peer-review articles.
Strategic Preparedness and Response for the new coronavirus (WHO)- This strategic preparedness and response plan outlines the public health measures that the international community stands ready to provide to support all countries to prepare for and respond to COVID-19.
UCSF Drs. Greg Marcus, Mark Pletcher and Jeffrey Olgin are using their Eureka Mobile Research Platform—an NIH funded digital research platform—to launch a world-wide study to track COVID-19 symptoms, infections, risk factors and behaviors that might impact spread. The study, called the COVID-19 Citizen Science Study, uses daily surveys to track risk factors, symptoms, exposures and COVID-19 diagnoses as well as geolocation to understand the impact of people’s movement on the containment of the disease.
EVENT: COVID-19 and AI: A Virtual Conference
Host: Stanford Institute for Human-Centered Artificial Intelligence
April 1, 2020
COVID-19 and AI: A Virtual Conference will address a developing public health crisis. Sponsored by the Stanford Institute for Human-Centered Artificial Intelligence (HAI), the event will convene experts from Stanford and beyond to advance the understanding of the virus and its impact on society. It will be livestreamed to engage the broad research community, government and international organizations, and civil society.
TRAVEL:
Travel Guidelines (CDC)- This page includes information about Coronavirus Disease 2019 (COVID-19) for travelers and travel related industries.
RDU Airport's travel updates here.